PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD

Antibody responses to SARS-CoV-2 infection and vaccination - Florian Krammer Ph.D.

Cancer immunotherapy - significant breakthrough or unrealised potential?

Neurobiology of Psychedelics II: Braintem, Subcortex, HPA & Gut-Brain Axes (Bray, 2025)

Понимание иммунотерапии НМРЛ с использованием биомаркеров PD-1 и PD-L1

NATURE AND BEYOND: Fc Mediated Enhancement of Anti-Viral Antibodies - Jon Yewdell, M.D., Ph.D.

PDL в толковом словаре онколога: Что? Где? Кому? (Завалишина Л.Э.)

The Latest in Immunotherapy to Treat Cancer

The Immunity Puzzle: What Drives Recovery or Chronic Disease?

Introduction to Immunotherapy (Immunotherapy Documentary Part I)

Patients with High PD-L1: Immunotherapy Alone or Combine with Chemo? - ASCO Lung Review 2022

Cancer Immune Checkpoint Inhibitors

Важные открытия XXI века: почему рак победил и что не так с клонированием? Что скрывают нобелевки?

Functional genomics of T cell metabolism and immuno-oncology - Hongbo Chi, Pd.D.

Immunotherapy using checkpoint inhibitors (subtitles)

Penetrating Solid Tumors with CAR Immune Cells

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD

How to interpret a PD-L1 immunostain

The Future of Cancer Immunotherapy with Dr. James Allison

Открытие Варбурга: 4 переключателя, которые мешают раку расти | Здоровье с Доктором

Cancer Immunotherapy Basics: Understand the science behind this cutting-edge treatment